Skip to content
Subscriber Only

How One Woman Silenced Her Twitter Trolls With a 78% Stock Rally

  • Biocon top generic drug stock as biosimilars bet bears fruit
  • Manufacturing biologics is costlier than chemical generics
Updated on

For more than two years Kiran Mazumdar-Shaw had a quarterly date with her Twitter trolls.

Every three months, after her Bangalore-based pharmaceutical company would deliver its earnings report, Mazumdar-Shaw says the trolls would emerge. They would tell the Biocon Ltd. managing director and co-founder that she was the country’s worst business leader, that she should give up her stake in the firm, and that she was the reason women shouldn’t run companies.